Lectenz Bio, Inc.
Publicly observedAthens, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Athens | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Lectenz Bio, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JTGCK219C6F4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant18 Jul 2025Publicly observed
NIH SBIR/STTR award: Innovative glycan-specific reagents to accelerate the detection of disease biomarkers
USD 1,044,652.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant18 Jul 2025Publicly observed
NIH SBIR/STTR award: Innovative glycan-specific reagents to accelerate the detection of disease biomarkers
USD 313,827.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2023Publicly observed
NIH SBIR/STTR award: Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
USD 999,973.00 · NIH Office of the Director · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.